Structure Therapeutics (GPCR) 10% Owner FMR LLC Sells ADS

What Happened FMR LLC, reported as a 10% owner, sold a total of 17,452 American Depositary Shares (ADS) of Structure Therapeutics in open-market transactions on July 22, 2026. The filing lists two dispositions: 1,367 ADS at $50.07 each ($68,446) and 16,085 ADS at $50.07 each ($805,376), for a combined proceeds of about $873,822. The filing classifies these as derivative transactions; the reported ADS represent three ordinary shares each (footnote F1).

Key Details

• Transaction date: 2026-07-22; Form 4 filed: 2026-07-24 (timely filing).
• Price: weighted average $50.07 (range $50.05–$50.20 across multiple trades; filer will provide trade details on request — footnote F2).
• Line items: 1,367 ADS sold for $68,446; 16,085 ADS sold for $805,376; total ≈ $873,822.
• Shares owned after transaction: not stated in the provided excerpt of the filing.
• Notable disclosures: FMR LLC is reported as a 10% owner; remarks note Abigail P. Johnson’s role and family ownership links to FMR and related entity structure (see filing remarks). The filing also includes a standard remark that it is not an admission of beneficial ownership for Section 16 purposes.

Context These are institutional sales by a large shareholder (FMR LLC and related parties), not an individual company executive. Sales of ADS simply indicate disposition of depositary shares (each ADS = 3 ordinary shares) and can reflect portfolio rebalancing or other institutional needs; they do not, by themselves, prove a change in company outlook. The filing appears timely (filed two days after the reported trades).